Allogene (ALLO) PT Raised to $66 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Allogene Therapeutics (ALLO) Prices 11.7M Share Common Offering at $47/Sh
June 2, 2020 5:50 AM EDTAllogene Therapeutics, Inc. (NASDAQ: ALLO), today announced the pricing of an underwritten public offering of 11,702,128 shares of its common stock at a price to the public of $47.00 per share. The gross proceeds from this offering are expected to be approximately $550.0 million, before deducting underwriting... More
Allogene Therapeutics (ALLO) Announces Proposed $450M Common Offering
June 1, 2020 6:31 AM EDTAllogene Therapeutics, Inc. (NASDAQ: ALLO), today announced the commencement of an underwritten public offering of $450.0 million of shares of its common stock. In addition, Allogene expects to grant the underwriters a 30-day option to purchase up to an additional $67.5 million of shares... More



